Por favor, use este identificador para citar o enlazar este ítem:
http://ipicyt.repositorioinstitucional.mx/jspui/handle/1010/2357
Toxicological Screening of Four Bioactive Citroflavonoids: In Vitro, In Vivo, and In Silico Approaches | |
ROLFFY RUBEN ORTIZ ANDRADE JESUS ALFREDO ARAUJO LEON AMANDA SANCHEZ RECILLAS JUAN GABRIEL NAVARRETE VAZQUEZ AVEL ADOLFO GONZALEZ SANCHEZ SERGIO NEMORIO HIDALGO FIGUEROA ANGEL JOSABAD ALONSO CASTRO Irma Aranda Gonzalez EMANUEL HERNANDEZ NUÑEZ TANIA ISOLINA CORAL MARTINEZ JUAN CARLOS SANCHEZ SALGADO VICTOR YAÑEZ PEREZ MONICA ARELY LUCIO GARCIA | |
Acceso Abierto | |
Atribución-NoComercial-SinDerivadas | |
https://doi.org/10.3390/molecules25245959 | |
Citroflavonoids Low-risk substances Acute oral toxicity MTT-based assay Toxicity prediction | |
"Many studies describe different pharmacological effects of flavonoids on experimental animals and humans. Nevertheless, few ones are confirming the safety of these compounds for therapeutic purposes. This study aimed to investigate the preclinical safety of naringenin, naringin, hesperidin, and quercetin by in vivo, in vitro, and in silico approaches. For this, an MTT-based cytotoxicity assay in VERO and MDCK cell lines was performed. In addition, acute toxicity was evaluated on Wistar rats by OECD Guidelines for the Testing of Chemicals (Test No. 423: Acute Oral Toxicity-Class Method). Furthermore, we used the ACD/Tox Suite to predict toxicological parameters such as hERG channel blockade, CYP450 inhibition, and acute toxicity in animals. The results showed that quercetin was slightly more cytotoxic on cell lines (IC50 of 219.44 ± 7.22 mM and 465.41 ± 7.44 mM, respectively) than the other citroflavonoids. All flavonoids exhibited an LD50 value > 2000 mg/kg, which classifies them as low-risk substances as OECD guidelines established. Similarly, predicted LD50 was LD50 > 300 to 2000 mg/kg for all flavonoids as acute toxicity assay estimated. Data suggests that all these flavonoids did not show significant toxicological effects, and they were classified as low-risk, useful substances for drug development." | |
MDPI | |
2020 | |
Artículo | |
Ortiz-Andrade, R.; Araujo-León, J.A.; Sánchez-Recillas, A.; Navarrete-Vazquez, G.; González-Sánchez, A.A.; Hidalgo-Figueroa, S.; Alonso-Castro, Á.J.; Aranda-González, I.; Hernández-Núñez, E.; Coral-Martínez, T.I.; Sánchez-Salgado, J.C.; Yáñez-Pérez, V.; Lucio-Garcia, M.A. Toxicological Screening of Four Bioactive Citroflavonoids: In Vitro, In Vivo, and In Silico Approaches. Molecules 2020, 25, 5959. https://doi.org/10.3390/molecules25245959 | |
BIOQUÍMICA | |
Versión publicada | |
publishedVersion - Versión publicada | |
Aparece en las colecciones: | Publicaciones Científicas Ciencias Ambientales |
Cargar archivos:
Fichero | Tamaño | Formato | |
---|---|---|---|
Molecules25(2020)5959.pdf | 966.94 kB | Adobe PDF | Visualizar/Abrir |